HSTM
HealthStream Inc
NASDAQ: HSTM · HEALTHCARE · HEALTH INFORMATION SERVICES
$28.36
+0.00% today
Updated 2026-08-12
Market cap
$839.77M
P/E ratio
39.89
P/S ratio
2.62x
EPS (TTM)
$0.72
Dividend yield
0.47%
52W range
$19 – $31
Volume
0.2M
WallStSmart proprietary scores
51
out of 100
Grade: C
Hold
Investment rating
6.0
Growth
B6.5
Quality
B5.0
Profitability
C+3.7
Valuation
D3/9
Piotroski F-Score
Weak
2.3
Altman Z-Score
Grey zone
—
Industry rank
—
View all highly rated stocks (75+) →219 stocks currently score above 75
Price targets
Analyst target
$34.50
+21.65%
12-Month target
$14.64
-48.38%
Intrinsic (DCF)
—
Margin of safety
—
0 Strong Buy2 Buy3 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Revenue growth 12.50% QoQ
+ Debt/equity 0.04x — low leverage
Risks
- Piotroski 3/9 — weak financial health
- Negative free cash flow $-1.73M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $266.83M | $279.06M | $291.65M | $304.06M | $321.12M |
| Net income | $12.09M | $15.21M | $20.01M | $18.34M | $6.67M |
| EPS | — | — | — | — | $0.72 |
| Free cash flow | $49.42M | $61.77M | $29.52M | $59.63M | $-1.73M |
| Profit margin | 4.53% | 5.45% | 6.86% | 6.03% | 6.60% |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-07-06 | REBROVICK, LINDA | Sale | 6,000 | $29.00 |
| 2026-06-08 | TAYLOR, TATE DEBORAH | Sale | 1,126 | — |
| 2026-06-08 | TAYLOR, TATE DEBORAH | Sale | 1,016 | — |
Peer comparison
Smart narrative
HealthStream Inc trades at $28.36. representing a P/E of 39.89x trailing earnings. Our Smart Value Score of 51/100 indicates the stock is fair. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of 2.33, it sits in the grey zone. TTM revenue stands at $321.12M. with profit margins at 6.60%.
Frequently asked questions
What is HealthStream Inc's stock price?
HealthStream Inc (HSTM) trades at $28.36, on a P/E of 39.9x and a P/S of 2.6x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is HealthStream Inc overvalued?
HealthStream Inc carries a Smart Value Score of 51/100 (Grade C), which we rate Hold. That score blends growth, quality, and valuation into one read.
What is the price target of HealthStream Inc (HSTM)?
The 12-month analyst consensus target is $34.50, about 21.7% above the current $28.36. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is the future stock price of HSTM by 2030?
Our research-backed model puts the 2030 base case at $18.57, built from revenue projections, a growth-adjusted P/S multiple, net debt, and share dilution. It is a scenario rather than a prediction, and the bull and bear cases around it matter more than the single number when you are sizing a position.
What is HealthStream Inc's revenue?
HealthStream Inc's trailing twelve-month revenue is $321.12M. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
HealthStream Inc's Altman Z-Score is 2.33, which places it in the grey zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryHEALTH INFORMATION SERVICES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio2.62x
ROE5.66%
Beta0.44
50D MA$27.13
200D MA$23.75
Shares out0.03B
Float0.02B
Short ratio—
Avg volume0.2M
Performance
1 week-1.44%
1 month+4.59%
3 months+25.73%
YTD+27.31%
1 year—
3 years—
5 years—